Syringaresinol reverses age-related skin atrophy by suppressing FoxO3a-mediated matrix metalloproteinase-2 activation in Copper/Zinc superoxide dismutase-deficient mice
ACS Infect Dis 1(7):288303
These alleles typically lead to a partial or complete loss of gene function, enabling the study of the effects resulting from the absence or reduction of gene expression
Cryo-EM density maps were deposited in the Electron Microscopy Data Bank with accession numbers EMD-47932 (a composite map of mTORC1RAGRagulator4E-BP1 on the membrane), EMD-47933 (focused refinement of the MLST8RAGRagulator subcomplex), EMD-47934 (mTORC1RAGRagulator4E-BP1 on the membrane with two extra RAGRagulator copies), EMD-47935 (mTORC1RAGRagulator4E-BP1 on the membrane with one extra RAGRagulator copy), EMD-47936 (mTORC1RAGRagulator4E-BP1 complex on the membrane with C 2 symmetry), EMD-47937 (focused refinement of mTORC1RAGRagulator4E-BP1 on the membrane with mTORMLST8RHEB mask), EMD-47938 (focused refinement of mTORC1RAGRagulator4E-BP1 on the membrane with RaptorRAGRagulator mask), EMD-47939 (fully active state of mTOR on the membrane) and EMD-47940 (intermediate state of mTOR on the membrane)
The short answer: semaglutide with B12 looks very similar to tirzepatide with B12
10.1017/s0031182000007071 Parasitology 105 SkellyP